A dynamic COVID-19 immune signature includes associations with poor prognosis

IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive Director, Strengthening its Board of Directors

IMU Biosciences announces formation of Scientific Advisory Board

IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies